BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 29547976)

  • 1. Argon preconditioning enhances postischaemic cardiac functional recovery following cardioplegic arrest and global cold ischaemia.
    Kiss A; Shu H; Hamza O; Santer D; Tretter EV; Yao S; Markstaller K; Hallström S; Podesser BK; Klein KU
    Eur J Cardiothorac Surg; 2018 Sep; 54(3):539-546. PubMed ID: 29547976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinase C isoform-dependent myocardial protection by ischemic preconditioning and potassium cardioplegia.
    Lu K; Otani H; Yamamura T; Nakao Y; Hattori R; Ninomiya H; Osako M; Imamura H
    J Thorac Cardiovasc Surg; 2001 Jan; 121(1):137-48. PubMed ID: 11135170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nitric oxide donor, S-nitroso human serum albumin, as an adjunct to HTK-N cardioplegia improves protection during cardioplegic arrest after myocardial infarction in rats.
    Trescher K; Dzilic E; Kreibich M; Gasser H; Aumayr K; Kerjaschki D; Pelzmann B; Hallström S; Podesser BK
    Interact Cardiovasc Thorac Surg; 2015 Mar; 20(3):387-94. PubMed ID: 25468794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardioprotection with esmolol cardioplegia: efficacy as a blood-based solution.
    Fujii M; Chambers DJ
    Eur J Cardiothorac Surg; 2013 Mar; 43(3):619-27. PubMed ID: 22715477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quinaprilat during cardioplegic arrest in the rabbit to prevent ischemia-reperfusion injury.
    Korn P; Kröner A; Schirnhofer J; Hallström S; Bernecker O; Mallinger R; Franz M; Gasser H; Wolner E; Podesser BK
    J Thorac Cardiovasc Surg; 2002 Aug; 124(2):352-60. PubMed ID: 12167796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New HTK-N46B cardioplegia provides superior protection during ischemia/reperfusion in failing hearts.
    Trescher K; Hasun M; Baumgartner A; Dietl W; Wolfsberger M; Hallström S; Podesser BK
    J Cardiovasc Surg (Torino); 2013 Jun; 54(3):413-21. PubMed ID: 23389583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional, metabolic and ultrastructure evidence for improved myocardial protection during severe ischaemic stress with MBS, a new crystalloid cardioplegic solution.
    Choong YS; Gavin JB
    J Cardiovasc Surg (Torino); 1996 Jun; 37(3):275-84. PubMed ID: 8698764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dose-response study of glutamate supplementation in isolated, perfused rat hearts undergoing ischaemia and cold cardioplegia.
    Kimose HH; Randsbæk F; Christensen TD; Valen G; Bøtker HE; Vaage J
    Eur J Cardiothorac Surg; 2018 Mar; 53(3):664-671. PubMed ID: 29069350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioprotection by sevoflurane against reperfusion injury after cardioplegic arrest in the rat is independent of three types of cardioplegia.
    Ebel D; Preckel B; You A; Müllenheim J; Schlack W; Thämer V
    Br J Anaesth; 2002 Jun; 88(6):828-35. PubMed ID: 12173202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness of ischemic preconditioning on myocardial protection and comparison with K(+) cardioplegia.
    Dernek S; Ikizler M; Uyguç O; Alatas O; Kural T
    Cardiovasc Surg; 2000 Oct; 8(6):466-73. PubMed ID: 10996102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preconditioning improves cardiac function after global ischemia, but not after cold cardioplegia.
    Valen G; Takeshima S; Vaage J
    Ann Thorac Surg; 1996 Nov; 62(5):1397-403. PubMed ID: 8893575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model.
    du Toit EF; Genade S; Carlini S; Moolman JA; Brunner F; Lochner A
    Eur J Pharmacol; 2007 Feb; 556(1-3):115-20. PubMed ID: 17157294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic and functional effects of carbachol and ischaemic preconditioning in rat isolated heart.
    Pisarenko OI; Shulzhenko VS; Studneva IM
    Clin Exp Pharmacol Physiol; 1999 Jan; 26(1):26-31. PubMed ID: 10027066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of myocardial reperfusion injury by poly(ADP-ribose) synthetase inhibitor, 3-aminobenzamide, in cardioplegic solution: in vitro study of isolated rat heart model.
    Yamazaki K; Miwa S; Ueda K; Tanaka S; Toyokuni S; Unimonh O; Nishimura K; Komeda M
    Eur J Cardiothorac Surg; 2004 Aug; 26(2):270-5. PubMed ID: 15296882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardioprotective effects of cariporide as an adjunct in different cardioplegic solutions: an experiment with rabbits].
    Zhou RH; Long C; Liu J; Liu B
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(33):2320-3. PubMed ID: 18036293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astragalin and dihydromyricetin as adjuncts to histidine‑tryptophan‑ketoglutarate cardioplegia enhances protection during cardioplegic arrest.
    Wang D; Zhang X; Qu D; Han J; Meng F; Xu M; Zheng Q
    Mol Med Rep; 2018 Sep; 18(3):2929-2936. PubMed ID: 30015889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of hydrogen sulphide on ischaemia-reperfusion injury and ischaemic preconditioning in the isolated, perfused rat heart.
    Bliksøen M; Kaljusto ML; Vaage J; Stensløkken KO
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):344-9. PubMed ID: 18455926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardioprotective effects of low-dose cyclosporin A added to histidine-tryptophan-ketoglutarate cardioplegia solution prior to total myocardial ischemia: an in vitro rabbit heart study.
    Pritzwald-Stegmann P; Hoyer A; Kempfert J; Dhein S; Mohr FW
    Pharmacology; 2011; 88(3-4):167-73. PubMed ID: 21952163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldehyde dehydrogenase-2 activation during cardioplegic arrest enhances the cardioprotection against myocardial ischemia-reperfusion injury.
    Gong D; Zhang Y; Zhang H; Gu H; Jiang Q; Hu S
    Cardiovasc Toxicol; 2012 Dec; 12(4):350-8. PubMed ID: 22814936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial protection during prolonged ischaemic cardiac arrest: experimental evaluation of three crystalloid cardioplegic solutions.
    Chong YS; Cottier DS; Gavin JB
    J Cardiovasc Surg (Torino); 1994 Feb; 35(1):35-44. PubMed ID: 8120076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.